Ken Griffin's position in Regeneron Pharmaceuticals is currently worth $266 Million. That's 0.27% of their equity portfolio (55th largest holding). The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Ken Griffin bought shares 54 more times and sold shares on 45 occasions. The stake costed the investor $140 Million, netting the investor a gain of 89% so far.